Taking out a loan for someone you love might seem like a gesture of trust and commitment — but if the relationship ends, you could be stuck with the debt. That's exactly what happened to Lily, a woman from New York who called into The Ramsey Show to speak with hosts Ken Coleman and George Kamel. Lily took out a $35,000 loan to help her then-boyfriend pay off his credit card debt. The loan, at an 11.49% interest rate, was in her name — because he couldn’t qualify for favorable terms on his own. Now the re ...

Phio Pharmaceuticals to Present at the Life Sciences Future ConferenceKey updates to include advances made in the on-going clinical trial for INTASYL siRNA lead product candidate PH-762September 18, 2025 7:45 AM EDT | Source: Phio Pharmaceuticals Corp.King of Prussia, Pennsylvania--(Newsfile Corp. - September 18, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biopharmaceutical company developing therapeutics using its proprietary INTASYL® siRNA gene silencing technology ...

At 7:25 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening bell.For active traders, premarket trading offers a head start in spotting potential breakouts, reversals, or sharp price swings. These early moves often indicate where momentum may carry into the regular session, making premarket analysis a key part of the trading day.In the Green - Premarket GainersThe following stocks are trading hig ...

Medical device maker GE Healthcare is working with advisers to explore options including the sale of a stake in its China unit, Bloomberg News reported on Thursday, citing people familiar with the mat... ...

Apple (NASDAQ:AAPL) is looking into test production of the widely speculated foldable iPhone: in Taiwan, having held talks with various suppliers, Nikkei Asia reported. If the tests go well, the tech giant and its manufacturing partners could begin mass production of ...

HSBC downgraded Grab Holdings (GRAB) to Hold from Buy with a price target of $6.20, up from $6. The firm says it is “time for a breather” following the stock’s 30% rally off last month’s low. However, Grab’s growth levers remain intact and the company should continue to strengthen its leadership position, the analyst tells investors in a research note. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insigh ...

Nestle's new chairman Pablo Isla, who helped to turn Zara owner Inditex into a world-leading fast-fashion retailer, can use his expertise in logistics, e-commerce, and consumer trends to try to revitalise the Swiss food company. ...

Biogen to drive end-to-end development and commercialization of ThecaFlex DRx™, an investigational implantable device for intrathecal delivery of antisense oligonucleotides (ASOs)ThecaFlex DRx™ has the potential to be a new, convenient way to administer medicines to patients living with neurological disorders. CAMBRIDGE, Mass., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced the company has entered into a definitive agreement to acquire Massachusetts-based Alcyone Therapeutics. As pa ...

Market Analysis by covering: S&P 500, Intel Corporation, NVIDIA Corporation, S&P 500 Futures. Read 's Market Analysis on Investing.com ...

Photronics, Inc. (NASDAQ: PLAB ) presents a compelling investment opportunity as an undervalued, critical player in the semiconductor supply chain. While the semiconductor industry is currently at the trough of a cyclical downturn, all signs are pointing to aAs a former managing editor at a financial media publication focused on mid and small caps, I am using my experience to present investment opportunities in undervalued companies. My experience, combined with my academic background in financial markets a ...